ODI PHARMA AB (6OD) — Defensive Interval Ratio
ODI PHARMA AB (6OD) has a Defensive Interval Ratio of 23 days as of June 2026. Defensive assets of €180.64K (cash €-, short-term investments €-, receivables €180.64K) cover 23 days of daily cash needs of €8.02K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ODI PHARMA AB Defensive Interval Ratio (2022–2026)
This chart shows how ODI PHARMA AB's Defensive Interval Ratio has evolved across 5 annual periods from 2022 to 2026. As of June 2026, the ratio stands at 23 days, meaning defensive assets of €180.64K can fund 23 days of operations without new revenue. For the complete balance sheet picture, see 6OD current and non-current assets.
Annual Defensive Interval Ratio for ODI PHARMA AB (2022–2026)
The table below presents the year-by-year Defensive Interval Ratio for ODI PHARMA AB from 2022 to 2026, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See 6OD working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2026 | 23 days | €180.64K | €8.02K/day | €- | €- | ▲ +12 days |
| 2025 | 10 days | €115.58K | €11.47K/day | €- | €- | ▼ -278 days |
| 2024 | 288 days | €8.07 Million | €28.02K/day | €- | €- | ▲ +280 days |
| 2023 | 9 days | €132.61K | €15.38K/day | €- | €- | ▼ -23 days |
| 2022 | 32 days | €108.63K | €3.39K/day | €- | €- | — |